Polyclonal Rabbit anti‑Human CCL22 / MDC Antibody (Biotin, aa25‑93, WB) LS‑C683992
Polyclonal Rabbit anti‑Human CCL22 / MDC Antibody (Biotin, aa25‑93, WB) LS‑C683992
Antibody:
CCL22 / MDC Rabbit anti-Human Polyclonal (aa25-93) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
CCL22 / MDC Rabbit anti-Human Polyclonal (aa25-93) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
MDC antibody LS-C683992 is a biotin-conjugated rabbit polyclonal antibody to human MDC (CCL22) (aa25-93). Validated for WB.
Target
Human CCL22 / MDC
Synonyms
CCL22 | A-152E5.1 | ABCD-1 | CC chemokine STCP-1 | DC/B-CK | Macrophage-derived chemokine | MDC(1-69) | MDC | SCYA22 | Small inducible cytokine A22 | STCP-1 | C-C motif chemokine 22 | Small-inducible cytokine A22
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
Cy3,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant MDC (Gly25-Gln93) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against MDC.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Rat
Applications:
IHC
Species:
Mouse
Applications:
Western blot, ELISA
Species:
Human
Applications:
ELISA
Species:
Human
Applications:
ELISA
Species:
Human
Applications:
IHC, Western blot, ELISA
Species:
Human, Rat
Applications:
IHC, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/20/2024